Company intelligence / Profile preview
Elevian
Allston, Massachusetts, United Stateselevian.com ↗
- Ownership
- Private
- Employees
- ~50
- Development stage
- Other
01
Overview
Elevian is developing medicines that restore youthful regenerative capacity, with a focus on recombinant GDF11 (rGDF11) for stroke recovery and other age-related diseases. Their research showed that GDF11 can repair heart, brain, muscle and other tissues in animal models.
- Therapeutic areas
- CardiovascularMetabolic DisordersEndocrinologyOtherNeurology
- Modalities
- Recombinant proteins (specifically recombinant GDF11)
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Elevian.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Elevian.